Chinese Company May Help Ease US Shortage of Cancer Drug
When importing drugs, the FDA stressed that regulators carefully assess product quality and manufacturing processes to ensure patient safety
When importing drugs, the FDA stressed that regulators carefully assess product quality and manufacturing processes to ensure patient safety
Study findings highlight the need for earlier mCSPC treatment intensification by urologists and oncologists.
Trimodality therapy produces similar oncologic outcomes as radical cystectomy in patients with muscle-invasive bladder cancer, a new study suggests.
The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC.
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Renal function declines slightly in the first year of follow-up and then remains stable through 10 years.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Study findings suggest that chemoradiation therapy could be considered an alternative to surgery in this patient population.
Compared with White patients, Black patients have 71% higher odds of cardiotoxicity
Clinicians may have limited awareness of maintenance immunotherapy for urothelial carcinoma.